An investigation of the role of gene copy number variations in sorafenib sensitivity in metastatic hepatocellular carcinoma patients

Background: Metastatic hepatocellular carcinoma (HCC) is a highly aggressive tumor with limited treatment options. While sorafenib has recently been shown to provide a survival advantage in patients with advanced HCC, the overall outcomes such as time to progression (TTP) and overall survival (OS) o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji Yun, Hong, Mineui, Lee, Jeeyun, Lee, Sujin, Kim, Kyoung-Mee, Park, Cheolkeun, Lim, Ho Yeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381160/
https://www.ncbi.nlm.nih.gov/pubmed/28382134
http://dx.doi.org/10.7150/jca.17887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381160/
https://www.ncbi.nlm.nih.gov/pubmed/28382134
http://dx.doi.org/10.7150/jca.17887

Ejemplares similares